As of September 2026 Genscript Biotech has a market cap of NZ$18.83 Billion. This makes Genscript Biotech the world's 1923th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.